IBDEI0LC ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9462,2)
 ;;=^5133346
 ;;^UTILITY(U,$J,358.3,9463,0)
 ;;=E11.00^^72^644^9
 ;;^UTILITY(U,$J,358.3,9463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9463,1,3,0)
 ;;=3^HHNS w/o Coma
 ;;^UTILITY(U,$J,358.3,9463,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,9463,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,9464,0)
 ;;=E11.01^^72^644^10
 ;;^UTILITY(U,$J,358.3,9464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9464,1,3,0)
 ;;=3^HHNS w/ Coma
 ;;^UTILITY(U,$J,358.3,9464,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,9464,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,9465,0)
 ;;=E11.40^^72^644^11
 ;;^UTILITY(U,$J,358.3,9465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9465,1,3,0)
 ;;=3^Type 2 DM w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,9465,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,9465,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,9466,0)
 ;;=E11.8^^72^644^12
 ;;^UTILITY(U,$J,358.3,9466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9466,1,3,0)
 ;;=3^Type 2 DM w/ Complications
 ;;^UTILITY(U,$J,358.3,9466,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,9466,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,9467,0)
 ;;=E13.10^^72^644^7
 ;;^UTILITY(U,$J,358.3,9467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9467,1,3,0)
 ;;=3^Diabetic Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,9467,1,4,0)
 ;;=4^E13.10
 ;;^UTILITY(U,$J,358.3,9467,2)
 ;;=^5002669
 ;;^UTILITY(U,$J,358.3,9468,0)
 ;;=E16.2^^72^644^1
 ;;^UTILITY(U,$J,358.3,9468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9468,1,3,0)
 ;;=3^Hypoglycemia
 ;;^UTILITY(U,$J,358.3,9468,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,9468,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,9469,0)
 ;;=E21.3^^72^644^40
 ;;^UTILITY(U,$J,358.3,9469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9469,1,3,0)
 ;;=3^Hyperparathyroidism
 ;;^UTILITY(U,$J,358.3,9469,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,9469,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,9470,0)
 ;;=E83.42^^72^644^27
 ;;^UTILITY(U,$J,358.3,9470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9470,1,3,0)
 ;;=3^Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,9470,1,4,0)
 ;;=4^E83.42
 ;;^UTILITY(U,$J,358.3,9470,2)
 ;;=^5003003
 ;;^UTILITY(U,$J,358.3,9471,0)
 ;;=E86.0^^72^644^19
 ;;^UTILITY(U,$J,358.3,9471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9471,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,9471,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,9471,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,9472,0)
 ;;=E87.70^^72^644^21
 ;;^UTILITY(U,$J,358.3,9472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9472,1,3,0)
 ;;=3^Fluid Overload
 ;;^UTILITY(U,$J,358.3,9472,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,9472,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,9473,0)
 ;;=E87.6^^72^644^22
 ;;^UTILITY(U,$J,358.3,9473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9473,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,9473,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,9473,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,9474,0)
 ;;=E87.1^^72^644^24
 ;;^UTILITY(U,$J,358.3,9474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9474,1,3,0)
 ;;=3^Hyponatremia & Hypoosmolality
 ;;^UTILITY(U,$J,358.3,9474,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,9474,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,9475,0)
 ;;=E87.0^^72^644^25
 ;;^UTILITY(U,$J,358.3,9475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9475,1,3,0)
 ;;=3^Hypernatemia & Hyperosmolality
 ;;^UTILITY(U,$J,358.3,9475,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,9475,2)
 ;;=^5003018
